CARES : Customized Aftercare Report for Evaluated Skin Cancer Patients

by palligoelme@gmail.com | Jan 9, 2026 | Clinical Trials

​ Conditions: Management; Low Risk; Skin Cancer Interventions: Behavioral: Verbal information only; Behavioral: Personalized Discharge Letter; Behavioral: Personalized Discharge Letter + IntelliStudio Sponsors: Universitaire Ziekenhuizen KU Leuven Not yet...

The Efficacy of High-Power Laser Therapy in Meralgia Paresthetica

by palligoelme@gmail.com | Jan 9, 2026 | Clinical Trials

​ Conditions: Meralgia Paresthetica Interventions: Device: High-power laser; Other: Sham laser; Other: Standard Conservative Care Sponsors: Uşak University; Balikesir University Not yet recruiting Conditions: Meralgia Paresthetica Interventions: Device: High-power...

A Prospective Cohort Study on Prognostic Factors in Patients With Cardiovascular-kidney-metabolic Syndrome

by palligoelme@gmail.com | Jan 8, 2026 | Clinical Trials

​ Conditions: Patient With Cardiovascular-kidney-metabolic Syndrome Sponsors: Peking University Third Hospital Recruiting Conditions: Patient With Cardiovascular-kidney-metabolic Syndrome Sponsors: Peking University Third Hospital...

Effect of Exercises on Ventilatory Function in Adult With TOF

by palligoelme@gmail.com | Jan 8, 2026 | Clinical Trials

​ Conditions: Tetralogy of Fallot (TOF); Adults With Repaired Tetralogy of Fallot Interventions: Other: aerobic exercise; Other: respiratory muscle training Sponsors: Cairo University Not yet recruiting Conditions: Tetralogy of Fallot (TOF); Adults With Repaired...

Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset

by palligoelme@gmail.com | Jan 8, 2026 | Clinical Trials

​ Conditions: Ischemic Stroke, Acute Interventions: Drug: non-immunogenic staphylokinase; Drug: Placebo Sponsors: Supergene, LLC Not yet recruiting Conditions: Ischemic Stroke, Acute Interventions: Drug: non-immunogenic staphylokinase; Drug: Placebo Sponsors:...

Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)

by palligoelme@gmail.com | Jan 8, 2026 | Clinical Trials

​ Conditions: Lipoprotein Disorder Interventions: Drug: Kylo-11 or matched placebo Sponsors: Kylonova (Xiamen) Biopharma co., LTD. Recruiting Conditions: Lipoprotein Disorder Interventions: Drug: Kylo-11 or matched placebo Sponsors: Kylonova (Xiamen) Biopharma co.,...